rs373072443
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM5PP3PP5_Very_Strong
The NM_001849.4(COL6A2):c.2488C>T(p.Arg830Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000373 in 1,608,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R830Q) has been classified as Pathogenic.
Frequency
Consequence
NM_001849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.2488C>T | p.Arg830Trp | missense_variant | 28/28 | ENST00000300527.9 | NP_001840.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.2488C>T | p.Arg830Trp | missense_variant | 28/28 | 1 | NM_001849.4 | ENSP00000300527 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152220Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000339 AC: 8AN: 236068Hom.: 0 AF XY: 0.0000309 AC XY: 4AN XY: 129444
GnomAD4 exome AF: 0.0000385 AC: 56AN: 1456250Hom.: 0 Cov.: 33 AF XY: 0.0000387 AC XY: 28AN XY: 724448
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152338Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74506
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | May 04, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 09, 2023 | - - |
Bethlem myopathy 1A Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 12, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg830 amino acid residue in COL6A2. Other variant(s) that disrupt this residue have been observed in individuals with COL6A2-related conditions (PMID: 29419890), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL6A2 protein function. ClinVar contains an entry for this variant (Variation ID: 287934). This missense change has been observed in individual(s) with autosomal recessive Bethlem myopathy and/or limb-girdle muscular dystrophy (PMID: 19884007, 30564623, 31127727, 34167565). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 830 of the COL6A2 protein (p.Arg830Trp). - |
Collagen 6-related myopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | May 09, 2017 | The COL6A2 c.2488C>T (p.Arg830Trp) missense variant has been reported in two studies and is found in a compound heterozygous state in a total of three individuals, including two siblings with recessive Bethlem myopathy and an unrelated individual with a recessive limb-girdle muscular dystrophy phenotype (Foley et al. 2009; Mitsui et al. 2016). The variant was also identified in a heterozygous state in the unaffected father of the siblings. Control data are unavailable for this variant, which is reported at a frequency of 0.00004 in the Total population of the Exome Aggregation Consortium. Foley et al. (2009) performed collagen VI staining using dermal fibroblasts from one of the siblings and found that collagen VI was deposited but differed in appearance and amount compared to collagen VI deposited by normal fibroblasts. Based on the evidence, the p.Arg830Trp variant is classified as likely pathogenic for recessive collagen type VI-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Ullrich congenital muscular dystrophy 1A Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant c.2488C>T (p.Arg830Trp) in COL6A2 gene has been reported in two studies and is found in a compound heterozygous state in a total of three individuals, including two siblings with recessive Bethlem myopathy and an unrelated individual with a recessive limb-girdle muscular dystrophy phenotype (Foley et al. 2009). This variant has been reported to the ClinVar database with conflicting interpretations of Uncertain Significance/Likely Pathogenic. The variant p.Arg830Trp is novel (not in any individuals) in 1000 Genomes and allele frequency of 0.003365% is reported in gnomAD. The amino acid Arg at position 830 is changed to a Trp changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted to be damaging by both SIFT and PolyPhen2. The residue is conserved across species. The amino acid change p.Arg830Trp in COL6A2 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. The observed variation is present in the father in a heterozygous state. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at